Log In
BCIQ
Print this Print this
 

PRT-500

  Manage Alerts
Collapse Summary General Information
Company Prothelia Inc.
DescriptionProtein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentDiscovery
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today